BIOSOLVE
LIVE

Serial Number

79142823

Owner

Biotronik AG

Attorney

Jennifer Fraser

Filing Date

Oct 29, 2013

Add to watchlist:

No watchlists yet
View on USPTO

BIOSOLVE Trademark

Serial Number: 79142823 • Registration: 4805843

BIOSOLVE is a trademark filed by Biotronik AG on October 29, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 6 (Metal Goods), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Biotronik AG (46 trademarks)

Ackerstrasse 6
Bülach CH-8180 , CH

Entity Type: 99

Trademark Details

Filing Date

October 29, 2013

Registration Date

September 8, 2015

Published for Opposition

June 23, 2015

Cancellation Date

October 28, 2023

Goods & Services

Common metals and their alloys; raw metal for manufacturing medical devices, stents and, markers; wire of common metals; pipes of metal; alloys of common metals; metal alloys for manufacture of medical devices, stents and markers; tantalum; magnesium; magnesium alloys; magnesium alloys for use in the manufacture stents; metals in powder form; brazing rods; alloys for brazing; metal moldings building

Chemical or pharmaceutical preparations for medical purposes, namely, pharmaceutical polymer preparations and polylactide-limus preparations, for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; chemical or pharmaceutical preparations for medical devices, namely, coatings for medical devices and stents; chemical preparations for pharmaceutical purposes, namely, pharmaceutical polymer preparations for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; medicines for medical purposes, namely, pharmaceutical preparations belonging to the paclitaxel family of medicines, and pharmaceutical preparations belonging to the limus family of medicines, particularly, sirolimus, everolimus, biolimus A9, zotarolimus, tacrolimus and pimecrolimus and limus derivatives, all for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; surgical implants comprising living tissue; pharmaceutical preparations for human use, for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; metal alloys for medical purposes; magnesium alloys for medical purposes

Surgical and medical apparatus and instruments, namely, vascular and cardiovascular equipment and implants; catheters, namely, catheters for balloon dilatation, catheters for percutaneous transluminal coronary angioplasty (PTCA), catheters for percutaneous transluminal angioplasty (PTA), catheters for percutaneous coronary intervention (PCI), balloons for vessel dilatation, medical guidewires, medical instruments and apparatus, particularly stents, balloon stents, self-expanding stents, balloon expandable stents, drug-eluting stents, absorbable stents, absorbable scaffolds, surgical implants comprised of artificial material

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
May 26, 2024 DENC
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
May 26, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
May 26, 2024 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Jan 30, 2023 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Dec 14, 2022 INTS
INVALIDATION PROCESSED
Dec 14, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 25, 2022 INTR
CANCELLED SECTION 71
Mar 25, 2022 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Jun 5, 2021 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 8, 2020 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 12, 2017 TCCA
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 17, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 23, 2016 FICS
FINAL DISPOSITION PROCESSED
Mar 23, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 8, 2015 FICR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 2, 2015 TCCA
REGISTERED-PRINCIPAL REGISTER
Sep 8, 2015 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 7, 2015 OPNX
NEW REPRESENTATIVE AT IB RECEIVED
Jul 23, 2015 NREP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 22, 2015 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 22, 2015 OPNR
PUBLISHED FOR OPPOSITION
Jun 23, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Jun 20, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 3, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 3, 2015 OP2R
NOTICE OF PUBLICATION
Jun 3, 2015 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 20, 2015 PREV
ASSIGNED TO LIE
May 20, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 27, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2015 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 27, 2015 ERFR
FINAL REFUSAL MAILED
Oct 28, 2014 CNFR
FINAL REFUSAL WRITTEN
Oct 27, 2014 CNFR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 10, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 10, 2014 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 9, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 8, 2014 TROA
REFUSAL PROCESSED BY IB
Mar 21, 2014 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 6, 2014 RFCS
REFUSAL PROCESSED BY MPU
Mar 6, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 4, 2014 RFCR
NON-FINAL ACTION WRITTEN
Mar 3, 2014 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 28, 2014 MAFR
ASSIGNED TO EXAMINER
Feb 24, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 21, 2014 REPR